Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$8.4M
Filings
58
Firms Hired
3
Active Period
2004–2014
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
SGR Repeal and Medicare Beneficiary Access Act of 2013
2013 · fourth_quarter · Firm: W STRATEGIES, LLC
H.R. 2810, S: Medicare Patient Access and Quality Improvement Act of 2013. Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2810
Protect Medical Innovation Act of 2013
2013 · fourth_quarter · Firm: W STRATEGIES, LLC
H.R. 523: Protect Medical Innovation Act of 2013.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 523
SGR Repeal and Medicare Beneficiary Access Act of 2013
2013 · fourth_quarter · Firm: W STRATEGIES, LLC
H.R. 2810, S: Medicare Patient Access and Quality Improvement Act of 2013. Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2810
Protect Medical Innovation Act of 2013
2013 · fourth_quarter · Firm: W STRATEGIES, LLC
H.R. 523: Protect Medical Innovation Act of 2013.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 523
Indonesian Family Refugee Protection Act
2013 · third_quarter · Firm: MEDIMMUNE, LLC.
Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis, federal quality, prevention of RSV and influenza; Medicaid coverage and reimbursement of biologics; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act;
Client expense: $240,000 · Firm income: —
Matched citations: H.R. 3590
Medicare Common Access Card Act of 2013
2013 · third_quarter · Firm: W STRATEGIES, LLC
H.R. 3089: Compounding Clarity Act of 2013. H.R. 3024: The Drug Quality and Security Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3024
Compounding Clarity Act of 2013
2013 · third_quarter · Firm: W STRATEGIES, LLC
H.R. 3089: Compounding Clarity Act of 2013. H.R. 3024: The Drug Quality and Security Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3089
To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines.
2013 · second_quarter · Firm: W STRATEGIES, LLC
H.R. 475: To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 475
Indonesian Family Refugee Protection Act
2013 · second_quarter · Firm: MEDIMMUNE, LLC.
HR 475 A bill to amend the Vaccine Injury Compensation Program; Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis and federal quality strategies for prevention of RSV; Medicaid coverage and reimbursement of biologics; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act
Client expense: $250,000 · Firm income: —
Matched citations: H.R. 3590
To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines.
2013 · second_quarter · Firm: MEDIMMUNE, LLC.
HR 475 A bill to amend the Vaccine Injury Compensation Program; Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis and federal quality strategies for prevention of RSV; Medicaid coverage and reimbursement of biologics; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act
Client expense: $250,000 · Firm income: —
Matched citations: HR 475
Integrated Electronic Health Records (iEHR) for Military and Veterans Act
2013 · first_quarter · Firm: SIDLEY AUSTIN LLP
HR 2055 - Provisions relating to health and human services funding, Center for Disease Control and Prevention, burden of disease study on repiratory syncytial virus
Client expense: — · Firm income: $50,000
Matched citations: HR 2055
To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines.
2013 · first_quarter · Firm: W STRATEGIES, LLC
H.R. 475: To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 475
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
2013 · first_quarter · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine developmentPrematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates. Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis and federal quality strategies for prevention of RSV. Proposed FY2014 Budgets Congressional and White House budgets--health care related provisions.
Client expense: $400,000 · Firm income: —
Matched citations: H.R. 2405
Indonesian Family Refugee Protection Act
2013 · first_quarter · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine developmentPrematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates. Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis and federal quality strategies for prevention of RSV. Proposed FY2014 Budgets Congressional and White House budgets--health care related provisions.
Client expense: $400,000 · Firm income: —
Matched citations: H.R. 3590
A bill to amend the Internal Revenue Code of 1986 to make permanent the reduced recognition period for built-in gains for S corporations.
2013 · first_quarter · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine developmentPrematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates. Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis and federal quality strategies for prevention of RSV. Proposed FY2014 Budgets Congressional and White House budgets--health care related provisions.
Client expense: $400,000 · Firm income: —
Matched citations: S. 1855
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
2012 · fourth_quarter · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679/S. 1440 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report H.R. 6687/S. 3176 A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Client expense: $190,000 · Firm income: —
Matched citations: H.R. 2405
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679/S. 1440 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report H.R. 6687/S. 3176 A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Client expense: $190,000 · Firm income: —
Matched citations: H.R. 2679
Indonesian Family Refugee Protection Act
2012 · fourth_quarter · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679/S. 1440 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report H.R. 6687/S. 3176 A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Client expense: $190,000 · Firm income: —
Matched citations: H.R. 3590
To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines.
2012 · fourth_quarter · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679/S. 1440 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report H.R. 6687/S. 3176 A bill to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system through a federal traceability standard; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Client expense: $190,000 · Firm income: —
Matched citations: H.R. 6687
American Taxpayer Relief Act of 2012
2012 · fourth_quarter · Firm: W STRATEGIES, LLC
H.R. 8: American Taxpayer Relief Act of 2012 as it relates to sequestration and Medicare, including updates to the Medicare Sustainable Growth rate formula for physicians and related issues.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 8
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
2012 · third_quarter · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Client expense: $190,000 · Firm income: —
Matched citations: H.R. 2405
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Client expense: $190,000 · Firm income: —
Matched citations: H.R. 2679
Indonesian Family Refugee Protection Act
2012 · third_quarter · Firm: MEDIMMUNE, LLC.
H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Client expense: $190,000 · Firm income: —
Matched citations: H.R. 3590
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
2012 · second_quarter · Firm: MEDIMMUNE, LLC.
S. 3187/Pub. L. No. 112-144 - Food and Drug Administration Safety and Innovation Act H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Client expense: $220,000 · Firm income: —
Matched citations: H.R. 2405
S. 3187/Pub. L. No. 112-144 - Food and Drug Administration Safety and Innovation Act H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.
Client expense: $220,000 · Firm income: —
Matched citations: H.R. 2679
Source: Senate LDA